HIV-1 latency modulators

Project Overview
Challenges
Category
Disciplines
University
Year
About
HIV-1 latency modulators aims to develop therapies targeting latent HIV-infected CD4+ T cells, which traditional treatments overlook. These cells house proviruses capable of reactivation. The "shock-and-kill" approach employs latency-reversing agents (LRAs) to activate these proviruses, enabling elimination via the host's immune response. This research identifies the plant Croton oligandrus as a potent antiviral. Extracts from this plant demonstrated latency-reversing potential and might serve as foundation materials for new HIV/AIDS cures.
Team
Gallery







